(PDF) Characteristics and Outcomes of Patients With Type 2

Characteristics and Outcomes of Patients With Type 2 Diabetes Mellitus Treated With Canagliflozin: A Real-World Analysis

BMC Endocrine Disorders - United Kingdom

doi 10.1186/s12902-015-0064-8

Full Text

Abstract

Available in full text

Categories

Date

November 2, 2015

Authors

Erin K. Buysman

Marcia F. T. Rupnow

Publisher

Springer Science and Business Media LLC

Related search

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients With Type 2 Diabetes Mellitus

Advances in Therapy

English

Beneficials Effects of Canagliflozin in a Weight-Centered Management in Patients With Type 2 Diabetes Mellitus in Real Practice

Endocrinology & Metabolic Syndrome

English

Effect of Canagliflozin on Serum Uric Acid in Patients With Type 2 Diabetes Mellitus

Diabetes, Obesity and Metabolism

Internal Medicine

English

Efficacy and Safety of Canagliflozin Compared With Placebo in Older Patients With Type 2 Diabetes Mellitus: A Pooled Analysis of Clinical Studies

BMC Endocrine Disorders

English

Clinical Characteristics in Patients With Type 2 Diabetes Mellitus: A Cohort Study

Endocrine Abstracts

English

Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes

Clinical Diabetes

Internal Medicine

English

Canagliflozin Improves Risk Factors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus and Metabolic Syndrome

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Internal Medicine

English

The CANVAS Program: Implications of Canagliflozin on Reducing Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus

Cardiovascular Diabetology

Internal Medicine

Cardiovascular Medicine

English

Real-World Evidence of Glycemic Control Among Patients With Type 2 Diabetes Mellitus in India: The TIGHT Study

BMJ Open Diabetes Research and Care

English